Mesenchymal Stem Cells May Ameliorate Nephrotic Syndrome Post-Allogeneic Hematopoietic Stem Cell Transplantation-Case Report

Mesenchymal Stem Cells May Ameliorate Nephrotic Syndrome Post-Allogeneic Hematopoietic Stem Cell Transplantation-Case Report

IntroductionBecause of their immunomodulatory and anti-inflammatory effects, mesenchymal stem cells (MSCs) have been considered as potential therapeutic agents for treating immune-related or autoimmune diseases, such as graft-versus-host disease (GVHD). Nephrotic syndrome (NS) after allogeneic hemat...

Full description

Bibliographic Details
Main Authors: Xin Zhang, Yanwen Peng, Zhiping Fan, Ke Zhao, Xiaoyong Chen, Ren Lin, Jing Sun, Guobao Wang, AndyPeng Xiang, Qifa Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-08-01
Series:Frontiers in Immunology
Subjects:
mesenchymal stem cells
allogeneic hematopoietic stem cell transplantation
nephrotic syndrome
chronic graft-versus-host disease
regulatory B cell
Online Access:http://journal.frontiersin.org/article/10.3389/fimmu.2017.00962/full

Internet

http://journal.frontiersin.org/article/10.3389/fimmu.2017.00962/full

Similar Items